Planavila A - Search Results

1

Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.

Planavila A, Rodríguez-Calvo R, de Arriba AF, Sánchez RM, Laguna JC, Merlos M, Vazquez-Carrera M. Planavila A, et al. Mol Pharmacol. 2006 Apr;69(4):1174-81. doi: 10.1124/mol.105.016345. Epub 2006 Jan 18. Mol Pharmacol. 2006. PMID: 16421291

2

Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue.

Jové M, Planavila A, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC, Carrera MV. Jové M, et al. Among authors: planavila a. Metabolism. 2003 Mar;52(3):351-5. doi: 10.1053/meta.2003.50055. Metabolism. 2003. PMID: 12647275 Clinical Trial.

3

Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.

Cabrero A, Cubero M, Llaverías G, Jové M, Planavila A, Alegret M, Sánchez R, Laguna JC, Carrera MV. Cabrero A, et al. Among authors: planavila a. Metabolism. 2003 May;52(5):652-7. doi: 10.1053/meta.2003.50100. Metabolism. 2003. PMID: 12759900

4

Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.

Cabrero A, Jové M, Planavila A, Merlos M, Laguna JC, Vázquez-Carrera M. Cabrero A, et al. Among authors: planavila a. Mol Pharmacol. 2003 Sep;64(3):764-72. doi: 10.1124/mol.64.3.764. Mol Pharmacol. 2003. PMID: 12920214

5

Impaired expression of NADH dehydrogenase subunit 1 and PPARgamma coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone.

Jové M, Salla J, Planavila A, Cabrero A, Michalik L, Wahli W, Laguna JC, Vázquez-Carrera M. Jové M, et al. Among authors: planavila a. J Lipid Res. 2004 Jan;45(1):113-23. doi: 10.1194/jlr.M300208-JLR200. Epub 2003 Oct 16. J Lipid Res. 2004. PMID: 14563825 Free article.

6

[Does the lipidic metabolism of myocardium modulate cardiac hypertrophy?].

Planavila A, Jové M, Cabrero A, Vázquez Carrera M. Planavila A, et al. Nefrologia. 2004;24 Suppl 4:29-33. Nefrologia. 2004. PMID: 15279383 Free article. Spanish. No abstract available.

7

Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

Planavila A, Laguna JC, Vázquez-Carrera M. Planavila A, et al. Biochim Biophys Acta. 2005 Feb 21;1687(1-3):76-83. doi: 10.1016/j.bbalip.2004.11.004. Biochim Biophys Acta. 2005. PMID: 15708355

8

Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.

Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC, Vázquez-Carrera M. Planavila A, et al. Cardiovasc Res. 2005 Mar 1;65(4):832-41. doi: 10.1016/j.cardiores.2004.11.011. Cardiovasc Res. 2005. PMID: 15721863

9

Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

Planavila A, Laguna JC, Vázquez-Carrera M. Planavila A, et al. J Biol Chem. 2005 Apr 29;280(17):17464-71. doi: 10.1074/jbc.M414220200. Epub 2005 Feb 22. J Biol Chem. 2005. PMID: 15728586 Free article.

10

Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice.

Planavila A, Alegret M, Sánchez RM, Rodríguez-Calvo R, Laguna JC, Vázquez-Carrera M. Planavila A, et al. Biochem Pharmacol. 2005 Apr 15;69(8):1195-204. doi: 10.1016/j.bcp.2005.01.015. Biochem Pharmacol. 2005. PMID: 15794940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters